Perspective Therapeutics (CATX) Free Cash Flow (2010 - 2026)

Perspective Therapeutics has disclosed Free Cash Flow across 17 years of filings, most recently posting -$34.8 million for Q2 2026.

• In Q2 2026, Free Cash Flow fell 66.09% year-over-year to -$34.8 million; the TTM figure through Jun 2026 stood at -$121.2 million (down 5.58% YoY), while the FY2025 annual figure was -$95.2 million, down 30.98% from the prior year.
• Free Cash Flow came in at -$34.8 million for Q2 2026 at Perspective Therapeutics, up from -$38.3 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $4.8 million in Q1 2024 to a low of -$41.2 million in Q4 2024.
• Average Free Cash Flow over 5 years is -$16.5 million, with a median of -$10.1 million recorded in 2023.
• Year-over-year, Free Cash Flow jumped 148.13% in 2024 and plunged 649.37% in 2025.
• Over 5 years, Free Cash Flow stood at -$6.2 million in 2022, then plunged by 45.86% to -$9.1 million in 2023, then slumped by 353.12% to -$41.2 million in 2024, then increased by 27.87% to -$29.7 million in 2025, then fell by 17.2% to -$34.8 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were -$34.8 million in Q2 2026, -$38.3 million in Q1 2026, and -$29.7 million in Q4 2025.